510(k) K253554

Aperio GT 450 DX; Aperio GT 180 DX by Leica Biosystems Imaging, Inc. — Product Code PSY

K253554 is an FDA 510(k) premarket notification submitted by Leica Biosystems Imaging, Inc. for the device "Aperio GT 450 DX; Aperio GT 180 DX". The FDA issued a decision of Substantially Equivalent on Aug 7, 2026. The device falls under product code PSY (Whole Slide Imaging System), a Class II device regulated under 21 CFR 864.3700. Leica Biosystems Imaging, Inc. has 4 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 7, 2026
Date Received
Nov 14, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Whole Slide Imaging System
Device Class
Class II
Regulation Number
864.3700
Review Panel
PA
Submission Type
510(k)

The whole slide imaging system is an automated digital slide creation, viewing, and management system intended as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed, paraffin-embedded (FFPE) tissue. The system generates digital images that would otherwise be appropriate for manual visualization by conventional brightfield microscopy. The whole slide imaging system is not intended for use with slides prepared from frozen tissue, cytology, and non-FFPE hematopathology specimens (e.g., peripheral blood smear).

Need the full FDA record for Leica Biosystems Imaging, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K253554. Report a data issue: hello@regdatalab.com.